Join
Live feed
·
PRReleasevia Quantisnow
MetaVia Inc. logo

MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction

ByQuantisnow·Wall Street's wire, on your screen.
MTVA· MetaVia Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MTVA (MetaVia Inc.) and more on Quantisnow.